All of the participants were placed on an 800 calorie-a-day diet plan and lost the average 24 pounds. Researchers then measured total fat, abdominal subcutaneous extra fat and visceral fat for each participant. Afterward, participants in the two exercise organizations were asked to keep exercising 40 minutes twice weekly for one year. After a year, the study’s participants were split into five groups: those who maintained aerobic fitness exercise training, those who stopped aerobic training, those who maintained their weight training, those who stopped resistance training and the ones who were never placed on an exercise program.According to the New York Situations, in an article today by Donald G. McNeil Jr., ‘Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis medications to the pool.’ THE CHANGING TIMES mentioned, ‘The pool was created last year, but drugmakers resisted it, attempting to control quality and protect rights to future earnings from middle-income countries. Until this full week, the just participant was the National Institutes of Health, which turned over a partial patent on an obscure AIDS medication.’ Related StoriesApplying a top restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiUnderstanding the causes of sudden loss of life in epilepsy: an interview with Professor Sanjay SisodiyaDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of Polyphotonix’We commend Gilead Sciences and chairman and CEO John Martin to be first among all the major AIDS drug companies to talk about some AIDS and hepatitis drug patents with the Medicines Patent Pool, a generous gesture which will do question ensure and improve access to newer AIDS remedies in many developing countries,’ stated Michael Weinstein, President of AIDS Healthcare Foundation.